Perspectives on genetic and genomic technologies in an academic medical center: The duke experience

Sara Huston Katsanis, Mollie A. Minear, Allison Vorderstrasse, Nancy Yang, Jason W. Reeves, Tejinder Rakhra-Burris, Robert Cook-Deegan, Geoffrey S. Ginsburg, Leigh Ann Simmons

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In this age of personalized medicine, genetic and genomic testing is expected to become instrumental in health care delivery, but little is known about its actual implementation in clinical practice. Methods. We surveyed Duke faculty and healthcare providers to examine the extent of genetic and genomic testing adoption. We assessed providers’ use of genetic and genomic testing options and indications in clinical practice, providers’ awareness of pharmacogenetic applications, and providers’ opinions on returning research-generated genetic test results to participants. Most clinician respondents currently use family history routinely in their clinical practice, but only 18 percent of clinicians use pharmacogenetics. Only two respondents correctly identified the number of drug package inserts with pharmacogenetic indications. We also found strong support for the return of genetic research results to participants. Our results demonstrate that while Duke healthcare providers are enthusiastic about genomic technologies, use of genomic tools outside of research has been limited. Respondents favor return of research-based genetic results to participants, but clinicians lack knowledge about pharmacogenetic applications. We identified challenges faced by this institution when implementing genetic and genomic testing into patient care that should inform a policy and education agenda to improve provider support and clinician-researcher partnerships.

Original languageEnglish (US)
Pages (from-to)67-82
Number of pages16
JournalJournal of Personalized Medicine
Volume5
Issue number2
DOIs
StatePublished - Apr 3 2015
Externally publishedYes

Fingerprint

Pharmacogenetics
Genetic Testing
Genetic Research
Technology
Health Personnel
Drug Labeling
Precision Medicine
Patient Care
Research Personnel
Delivery of Health Care
Education
Research
Surveys and Questionnaires

Keywords

  • Clinical implementation
  • Genetic tests
  • Genomic tests
  • Knowledge gaps
  • Personalized medicine
  • Pharmacogenetics
  • Physician education
  • Return of research results

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Katsanis, S. H., Minear, M. A., Vorderstrasse, A., Yang, N., Reeves, J. W., Rakhra-Burris, T., ... Simmons, L. A. (2015). Perspectives on genetic and genomic technologies in an academic medical center: The duke experience. Journal of Personalized Medicine, 5(2), 67-82. https://doi.org/10.3390/jpm5020067

Perspectives on genetic and genomic technologies in an academic medical center : The duke experience. / Katsanis, Sara Huston; Minear, Mollie A.; Vorderstrasse, Allison; Yang, Nancy; Reeves, Jason W.; Rakhra-Burris, Tejinder; Cook-Deegan, Robert; Ginsburg, Geoffrey S.; Simmons, Leigh Ann.

In: Journal of Personalized Medicine, Vol. 5, No. 2, 03.04.2015, p. 67-82.

Research output: Contribution to journalArticle

Katsanis, SH, Minear, MA, Vorderstrasse, A, Yang, N, Reeves, JW, Rakhra-Burris, T, Cook-Deegan, R, Ginsburg, GS & Simmons, LA 2015, 'Perspectives on genetic and genomic technologies in an academic medical center: The duke experience', Journal of Personalized Medicine, vol. 5, no. 2, pp. 67-82. https://doi.org/10.3390/jpm5020067
Katsanis SH, Minear MA, Vorderstrasse A, Yang N, Reeves JW, Rakhra-Burris T et al. Perspectives on genetic and genomic technologies in an academic medical center: The duke experience. Journal of Personalized Medicine. 2015 Apr 3;5(2):67-82. https://doi.org/10.3390/jpm5020067
Katsanis, Sara Huston ; Minear, Mollie A. ; Vorderstrasse, Allison ; Yang, Nancy ; Reeves, Jason W. ; Rakhra-Burris, Tejinder ; Cook-Deegan, Robert ; Ginsburg, Geoffrey S. ; Simmons, Leigh Ann. / Perspectives on genetic and genomic technologies in an academic medical center : The duke experience. In: Journal of Personalized Medicine. 2015 ; Vol. 5, No. 2. pp. 67-82.
@article{bb89015644464f678059bb4ee2ccd7d4,
title = "Perspectives on genetic and genomic technologies in an academic medical center: The duke experience",
abstract = "In this age of personalized medicine, genetic and genomic testing is expected to become instrumental in health care delivery, but little is known about its actual implementation in clinical practice. Methods. We surveyed Duke faculty and healthcare providers to examine the extent of genetic and genomic testing adoption. We assessed providers’ use of genetic and genomic testing options and indications in clinical practice, providers’ awareness of pharmacogenetic applications, and providers’ opinions on returning research-generated genetic test results to participants. Most clinician respondents currently use family history routinely in their clinical practice, but only 18 percent of clinicians use pharmacogenetics. Only two respondents correctly identified the number of drug package inserts with pharmacogenetic indications. We also found strong support for the return of genetic research results to participants. Our results demonstrate that while Duke healthcare providers are enthusiastic about genomic technologies, use of genomic tools outside of research has been limited. Respondents favor return of research-based genetic results to participants, but clinicians lack knowledge about pharmacogenetic applications. We identified challenges faced by this institution when implementing genetic and genomic testing into patient care that should inform a policy and education agenda to improve provider support and clinician-researcher partnerships.",
keywords = "Clinical implementation, Genetic tests, Genomic tests, Knowledge gaps, Personalized medicine, Pharmacogenetics, Physician education, Return of research results",
author = "Katsanis, {Sara Huston} and Minear, {Mollie A.} and Allison Vorderstrasse and Nancy Yang and Reeves, {Jason W.} and Tejinder Rakhra-Burris and Robert Cook-Deegan and Ginsburg, {Geoffrey S.} and Simmons, {Leigh Ann}",
year = "2015",
month = "4",
day = "3",
doi = "10.3390/jpm5020067",
language = "English (US)",
volume = "5",
pages = "67--82",
journal = "Journal of Personalized Medicine",
issn = "2075-4426",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Perspectives on genetic and genomic technologies in an academic medical center

T2 - The duke experience

AU - Katsanis, Sara Huston

AU - Minear, Mollie A.

AU - Vorderstrasse, Allison

AU - Yang, Nancy

AU - Reeves, Jason W.

AU - Rakhra-Burris, Tejinder

AU - Cook-Deegan, Robert

AU - Ginsburg, Geoffrey S.

AU - Simmons, Leigh Ann

PY - 2015/4/3

Y1 - 2015/4/3

N2 - In this age of personalized medicine, genetic and genomic testing is expected to become instrumental in health care delivery, but little is known about its actual implementation in clinical practice. Methods. We surveyed Duke faculty and healthcare providers to examine the extent of genetic and genomic testing adoption. We assessed providers’ use of genetic and genomic testing options and indications in clinical practice, providers’ awareness of pharmacogenetic applications, and providers’ opinions on returning research-generated genetic test results to participants. Most clinician respondents currently use family history routinely in their clinical practice, but only 18 percent of clinicians use pharmacogenetics. Only two respondents correctly identified the number of drug package inserts with pharmacogenetic indications. We also found strong support for the return of genetic research results to participants. Our results demonstrate that while Duke healthcare providers are enthusiastic about genomic technologies, use of genomic tools outside of research has been limited. Respondents favor return of research-based genetic results to participants, but clinicians lack knowledge about pharmacogenetic applications. We identified challenges faced by this institution when implementing genetic and genomic testing into patient care that should inform a policy and education agenda to improve provider support and clinician-researcher partnerships.

AB - In this age of personalized medicine, genetic and genomic testing is expected to become instrumental in health care delivery, but little is known about its actual implementation in clinical practice. Methods. We surveyed Duke faculty and healthcare providers to examine the extent of genetic and genomic testing adoption. We assessed providers’ use of genetic and genomic testing options and indications in clinical practice, providers’ awareness of pharmacogenetic applications, and providers’ opinions on returning research-generated genetic test results to participants. Most clinician respondents currently use family history routinely in their clinical practice, but only 18 percent of clinicians use pharmacogenetics. Only two respondents correctly identified the number of drug package inserts with pharmacogenetic indications. We also found strong support for the return of genetic research results to participants. Our results demonstrate that while Duke healthcare providers are enthusiastic about genomic technologies, use of genomic tools outside of research has been limited. Respondents favor return of research-based genetic results to participants, but clinicians lack knowledge about pharmacogenetic applications. We identified challenges faced by this institution when implementing genetic and genomic testing into patient care that should inform a policy and education agenda to improve provider support and clinician-researcher partnerships.

KW - Clinical implementation

KW - Genetic tests

KW - Genomic tests

KW - Knowledge gaps

KW - Personalized medicine

KW - Pharmacogenetics

KW - Physician education

KW - Return of research results

UR - http://www.scopus.com/inward/record.url?scp=85007201789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007201789&partnerID=8YFLogxK

U2 - 10.3390/jpm5020067

DO - 10.3390/jpm5020067

M3 - Article

AN - SCOPUS:85007201789

VL - 5

SP - 67

EP - 82

JO - Journal of Personalized Medicine

JF - Journal of Personalized Medicine

SN - 2075-4426

IS - 2

ER -